Long-term Results After Transcatheter Aortic Valve Implantation: What do we Know Today?

Transcatheter aortic valve implantation (TAVI) is evolving rapidly as a therapeutic option in patients deemed to be at high risk for surgical aortic valve replacement. Early outcome and survival of controlled feasibility trials and single- center experience with TAVI have been previously reported. Valve performance and hemodynamics seem to improve significantly after TAVI. Long-term outcome up to 3 years have been demonstrated in recent studies. Admittedly, the results are encouraging with a survival rate at 2 and 3 years ranging from 62 to 74% and from 56 to 61% respectively. The improvement in hemodynamical and clinical status sustained beyond the 3 years follows up. However, paravalvular leakage after TAVI remains an important issue in this rapidely evolving field.

[1]  P. Serruys,et al.  Frequency and causes of stroke during or after transcatheter aortic valve implantation. , 2012, The American journal of cardiology.

[2]  Scott Lim,et al.  Two-year outcomes after transcatheter or surgical aortic-valve replacement. , 2012, The New England journal of medicine.

[3]  A. Colombo,et al.  Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. , 2012, European heart journal.

[4]  R. V. van Geuns,et al.  Clinical outcome following transcatheter aortic valve implantation in patients with impaired left ventricular systolic function , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[5]  M. Mack,et al.  ACQUIRED CARDIOVASCULAR DISEASE Transcatheter ( TAVR ) versus surgical ( AVR ) aortic valve replacement : Occurrence , hazard , risk factors , and consequences of neurologic events in the PARTNER trial , 2012 .

[6]  A. Mügge,et al.  VALVULAR AND STRUCTURAL HEART DISEASES Original Studies Clinical Outcome of Transcatheter Aortic Valve Implantation in Patients With Low-Flow, Low Gradient Aortic Stenosis , 2012 .

[7]  R. Mueller,et al.  Early calcific degeneration of a CoreValve transcatheter aortic bioprosthesis. , 2012, European heart journal.

[8]  G. Schuler,et al.  Transapical aortic valve implantation at 3 years. , 2012, The Journal of thoracic and cardiovascular surgery.

[9]  R. Lange,et al.  Beyond the short-term: clinical outcome and valve performance 2 years after transcatheter aortic valve implantation in 227 patients. , 2012, The Journal of thoracic and cardiovascular surgery.

[10]  M. Deutsch,et al.  Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future. , 2012, Journal of the American College of Cardiology.

[11]  R. Hetzer,et al.  Transapical Aortic Valve Implantation Incidence and Predictors of Paravalvular Leakage and Transvalvular Regurgitation in a Series of 358 Patients , 2011 .

[12]  P. Wenaweser,et al.  Clinical Outcome of High-Risk Patients with Severe Aortic Stenosis and Reduced Left Ventricular Ejection Fraction Undergoing Medical Treatment or TAVI , 2011, PloS one.

[13]  Robert Bauernschmitt,et al.  Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  Ronen Gurvitch,et al.  Aortic annulus diameter determination by multidetector computed tomography: reproducibility, applicability, and implications for transcatheter aortic valve implantation. , 2011, JACC. Cardiovascular interventions.

[15]  Antonio Colombo,et al.  One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: The European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve , 2011, Circulation.

[16]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[17]  P. Serruys,et al.  2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. , 2011, Journal of the American College of Cardiology.

[18]  F. Maisano,et al.  Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis , 2011, Circulation.

[19]  Jeroen J. Bax,et al.  Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis. , 2010, American heart journal.

[20]  G. Schuler,et al.  Transapical Aortic Valve Implantation: Analysis of Risk Factors and Learning Experience in 299 Patients , 2010, Circulation.

[21]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[22]  P. Serruys,et al.  Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium , 2010, European heart journal.

[23]  E. Tay,et al.  Transcatheter Aortic Valve Implantation: Durability of Clinical and Hemodynamic Outcomes Beyond 3 Years in a Large Patient Cohort , 2010, Circulation.

[24]  Tristan D Yan,et al.  Transcatheter aortic valve implantation for high-risk patients with severe aortic stenosis: A systematic review. , 2010, The Journal of thoracic and cardiovascular surgery.

[25]  A. Mügge,et al.  Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. , 2010, American heart journal.

[26]  R. Rajani,et al.  Paravalvular regurgitation one year after transcatheter aortic valve implantation. , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[27]  Fabian Nietlispach,et al.  Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. , 2010, Journal of the American College of Cardiology.

[28]  T. Dewey,et al.  Transcatheter Aortic Valve Implantation , 2009, Innovations.

[29]  R. Lange,et al.  Valve implantation on the beating heart: catheter-assisted surgery for aortic stenosis. , 2009, Deutsches Arzteblatt international.

[30]  Lukas Altwegg,et al.  Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic Stenosis , 2007, Circulation.

[31]  Thomas Walther,et al.  Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. , 2007, Journal of the American College of Cardiology.

[32]  Thomas Felderhoff,et al.  Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study , 2006, Circulation.

[33]  Franz Schwarz,et al.  The Effect of Aortic Valve Replacement on Survival , 1982, Circulation.

[34]  M. Cheitlin.  United States Feasibility Study of Transcatheter Insertion of a Stented Aortic Valve by the Left Ventricular Apex , 2009 .